Invasive pulmonary aspergillosis after liver transplantation: lessons from successfully treated cases and review of the literature

Surg Today. 2021 Aug;51(8):1361-1370. doi: 10.1007/s00595-021-02263-z. Epub 2021 Mar 18.

Abstract

Purpose: Invasive pulmonary aspergillosis (IPA) after liver transplantation (LT) is most often fatal. We analyzed the outcomes of IPA in a single center.

Methods: We reviewed, retrospectively, the medical records of recipients of living donor LT (LDLT) or deceased donor LT (DDLT) performed between 1995 and 2019 at our institute. We analyzed the incidence of IPA and assessed the treatment courses of patients treated successfully and those not treatment successfully.

Results: Among 326 recipients, IPA was diagnosed in 6 (1.8%). The incidence of IPA was significantly higher in patients with acute liver failure (ALF, 9.8%) than in those without ALF (0.4%), after DDLT (8.8%) than after LDLT (1.0%), and in recipients who received preoperative steroid pulse therapy (16.0%) than in those who did not (0.7%). Complete cure of IPA was achieved in the most recent three patients, by administering voriconazole immediately after the diagnosis of IPA and performing lung resection, while the IPA lesion was single and localized.

Conclusions: Patients with risk factors for IPA must be monitored closely. Our three successfully treated cases demonstrate that initiating immediate voriconazole treatment and making a calculated decision about lung resection can contribute to a favorable outcome.

Keywords: Invasive pulmonary aspergillosis; Liver transplantation; Lung resection.

Publication types

  • Review

MeSH terms

  • Clinical Decision-Making
  • Female
  • Humans
  • Incidence
  • Liver Failure, Acute
  • Liver Transplantation / adverse effects*
  • Male
  • Middle Aged
  • Pneumonectomy
  • Postoperative Complications / epidemiology*
  • Postoperative Complications / etiology
  • Postoperative Complications / therapy*
  • Pulmonary Aspergillosis / epidemiology*
  • Pulmonary Aspergillosis / etiology
  • Pulmonary Aspergillosis / surgery*
  • Retrospective Studies
  • Risk Factors
  • Tissue Donors
  • Treatment Outcome
  • Voriconazole / administration & dosage*

Substances

  • Voriconazole